H. Lundbeck A/S has planned the following dates in 2009 for the
financial statements, the Annual General Meeting and payment of
annual dividend.
4 March 2009 Annual report 2008
21 April 2009 Annual General Meeting
27 April 2009 Payment of annual dividend
13 May 2009 Interim report for the first quarter of
2009
13 August 2009 Interim report for the second quarter of
2009
3 November 2009 Interim report for the third quarter of 2009
Lundbeck contacts
Investors: Media:
Jacob Tolstrup Jens Harder Højbjerg
Director Media Relations Manager
+45 36 43 30 79 +45 36 43 28 33
Palle Holm Olesen
Head of Investor Relations
+45 36 43 24 26
Release No 359 - 8 December 2008
About Lundbeck
H. Lundbeck A/S is an international pharmaceutical company engaged in
the research and development, production, marketing and sale of
pharmaceuticals for the treatment of psychiatric and neurological
disorders. In 2007, the company's revenue was DKK 11 billion
(approximately EUR 1.5 billion or USD 2.0 billion). The number of
employees is approx. 5,300 globally. For more information, please
visit www.lundbeck.com.
